Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public markets pitfalls.
Today, we examine once again, Filament Health (FH.NEO), a Canadian company leading the psychedelics sector in natural extraction of psilocybin. Having the first public company patent for its extraction technology, Filament is sitting in the catbird seat within this nascent industry.
Enjoy!
Equity Guru provides investment information for millennials and madmen. Expert analysis, no punches pulled and no investors left behind. Want to get involved in the public markets, but feel ill-equipped? Already in the markets, but looking for honest source of insight? We can provide the resources that keep you informed, help you build the necessary tools or assist in honing your existing skillset so you can make your investment goals achievable today. Small cap, mid cap, large cap, we cover them all.
No the matter the exchange be it, TSX-V, CSE, OTC, NYSE and/or NASDAQ, we have our finger on the pulse. Whether you are a day trader or value investor, we have your back.
Social Media:
https://twitter.com/equitydotguru
https://www.facebook.com/equitydotguru
https://www.linkedin.com/company/equity-guru
https://www.instagram.com/equity.guru
#Investment #Trading #StockMarket #Finance
Disclaimer: http://bit.ly/EGdisclaimer
source